In vivo assessment of the drug interaction between sorafenib and paracetamol in rats

PURPOSE: Sorafenib is a multi-targeted tyrosine kinase inhibitor (TKI) used for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma and radioactive iodine resistant thyroid carcinoma. Neoplastic diseases are the cause of pain, which may occur regardless of the stage of the disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Karbownik, Agnieszka, Sobańska, Katarzyna, Grabowski, Tomasz, Stanisławiak-Rudowicz, Joanna, Wolc, Anna, Grześkowiak, Edmund, Szałek, Edyta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305075/
https://www.ncbi.nlm.nih.gov/pubmed/32394097
http://dx.doi.org/10.1007/s00280-020-04075-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305075/
https://www.ncbi.nlm.nih.gov/pubmed/32394097
http://dx.doi.org/10.1007/s00280-020-04075-3

Ejemplares similares